Physician

Nickolas M Tyris, M.D.

According to 2025 Medicare claims, Nickolas Tyris, M.D. (NPI: 1821309154) practices rheumatology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is VIP RHEUMATOLOGY (NPI: 1457112484; TIN: 934106917) and primary practice location at 08054-1150. Tyris is affiliated with the Aledade 196 Advocare Collaborative Health MSSP (ACO ID: A5364), participating under the MSSP model.

Tyris' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 193 traditional Medicare patients, billed 79,770 HCPCS/CPT codes, and received $1,035,916 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,283 prescription claims across 240 beneficiaries totaling $3,817,955 in drug costs, led by Cortrophin (Corticotropin). DME data shows 12 claims. Open Payments data shows 176 records totaling $52,142. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $164,756 and ending at $1,035,916. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $152,020 and ending at $3,817,955. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	223	8,165	$164,756
2017	372	36,522	$543,944
2018	511	67,773	$943,997
2019	594	95,454	$1,334,544
2020	551	108,577	$1,441,524
2021	385	45,829	$568,933
2022	294	108,106	$1,139,436
2023	277	98,074	$1,547,845
2024	193	79,770	$1,035,916

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	59	408	$152,020
2016	137	533	$699,236
2017	323	1,394	$2,547,237
2018	448	2,216	$3,778,564
2019	637	3,087	$4,306,449
2020	562	3,763	$6,889,916
2021	447	1,844	$1,514,841
2022	319	1,702	$1,632,888
2023	310	1,722	$3,638,745
2024	240	1,283	$3,817,955

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	36	36	$26,931
2017	61	61	$32,359
2018	27	27	$20,534
2019	47	47	$30,088
2020	13	13	$10,273
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$74

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	87	88	$136
96413	Administration of chemotherapy into vein, 1 hour or less	38	165	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	167	501	$104
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	55	298	$62
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	136	257	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cortrophin	Corticotropin	20	736	$2,331,975
Simponi Aria	Golimumab	16	760	$133,270
Orencia	Abatacept/Maltose	22	410	$112,108
Humira(Cf) Pen	Adalimumab	16	464	$108,823
Cimzia (2 Pack)	Certolizumab Pegol	11	364	$83,625

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0730	Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation	Y	N/R	12	$74

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	176	$52,142	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nickolas M. Tyris, M.D.?

Tedicare shows public-source Medicare data for Nickolas M. Tyris, M.D. (NPI 1821309154), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nickolas M. Tyris, M.D. have ACO affiliation data?

Nickolas M. Tyris, M.D. is shown with ACO affiliation data for Aledade 196 Advocare Collaborative Health MSSP (MSSP, ACO ID A5364).

What billing organization is linked to Nickolas M. Tyris, M.D.?

Nickolas M. Tyris, M.D. is linked to VIP RHEUMATOLOGY (billing NPI 1457112484) in the available physician profile data.

Does Nickolas M. Tyris, M.D. have Open Payments data?

Nickolas M. Tyris, M.D. has 176 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.